We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pharma Equity Group A/s | LSE:0REU | London | Ordinary Share | DK0061155009 | PHARMA EQUITY GROUP ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | -24.61M | -0.0241 | -16.60 | 409.19M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 0.40 | DKK |
Date | Time | Source | Headline |
---|---|---|---|
23/10/2024 | 08:28 | UKREG | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained.. |
14/10/2024 | 06:17 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
14/10/2024 | 05:59 | UKREG | Managers’ transactions |
11/10/2024 | 06:37 | UKREG | Pharma Equity Group announces successful completion of directed issue of.. |
04/10/2024 | 11:52 | UKREG | Pharma Equity Group announces issuance of new shares in a direct issue |
04/10/2024 | 07:01 | UKREG | Registration of capital reduction by way of a reduction of the nominal.. |
16/8/2024 | 06:52 | UKREG | Consolidated Interim Report 1 January – 30 June 2024 |
16/7/2024 | 08:09 | UKREG | The Board of Directors' decision to issue convertible loans |
15/7/2024 | 14:22 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
15/7/2024 | 14:12 | UKREG | Major shareholder announcement - Pharma Equity Group A/S |
Pharma Equity Group A/s (0REU) Share Charts1 Year Pharma Equity Group A/s Chart |
|
1 Month Pharma Equity Group A/s Chart |
Intraday Pharma Equity Group A/s Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions